Neftaly Screening for Thyroid Dysfunction

Neftaly Email: info@neftaly.net Call/WhatsApp: + 27 84 313 7407

[Contact Neftaly] [About Neftaly][Services] [Recruit] [Agri] [Apply] [Login] [Courses] [Corporate Training] [Study] [School] [Sell Courses] [Career Guidance] [Training Material[ListBusiness/NPO/Govt] [Shop] [Volunteer] [Internships[Jobs] [Tenders] [Funding] [Learnerships] [Bursary] [Freelancers] [Sell] [Camps] [Events&Catering] [Research] [Laboratory] [Sponsor] [Machines] [Partner] [Advertise]  [Influencers] [Publish] [Write ] [Invest ] [Franchise] [Staff] [CharityNPO] [Donate] [Give] [Clinic/Hospital] [Competitions] [Travel] [Idea/Support] [Events] [Classified] [Groups] [Pages]

  • include:
    • Women > 60 years old
    • Patients with symptoms suggestive of thyroid disease (fatigue, weight changes, cold intolerance, palpitations, depression)
    • History of autoimmune diseases (e.g., type 1 diabetes, rheumatoid arthritis)
    • Family history of thyroid disease
    • Patients with neck irradiation or goiter
    • Pregnant women or those planning pregnancy
      (American Thyroid Association Guidelines)

2. Screening Tests

  • TSH (Thyroid Stimulating Hormone) is the preferred initial screening test due to its sensitivity.
  • If TSH is abnormal:
    • Check Free T4 (to distinguish hypo- vs hyperthyroidism)
    • Consider thyroid antibodies (e.g., anti-TPO) if autoimmune thyroiditis suspected.

3. Interpreting Results

TSH LevelInterpretationNext Steps
Normal (0.4–4.0 mIU/L)Euthyroid (normal)No action unless symptomatic
Elevated (>4.0 mIU/L)Possible hypothyroidismCheck Free T4; consider treatment if low or symptomatic
Suppressed (<0.4 mIU/L)Possible hyperthyroidismCheck Free T4; refer for further evaluation

4. When to Refer

  • Confirmed overt hypo- or hyperthyroidism
  • Presence of thyroid nodules or goiter on examination
  • Pregnant women with abnormal thyroid tests
  • Patients with severe symptoms or complications

5. Patient Education & Follow-Up

  • Educate patients on symptoms and importance of follow-up
  • Repeat testing as per clinical context (e.g., 6–12 months for subclinical disease)
  • Encourage adherence to prescribed therapy and lifestyle modifications

Summary Table: Thyroid Dysfunction Screening

StepKey Points
Target PopulationHigh-risk groups, symptomatic patients
Initial TestSerum TSH
Follow-up TestingFree T4, antibodies if indicated
Referral CriteriaOvert disease, nodules, pregnancy
Patient EducationSymptoms, importance of follow-up

If you want, I can help you design easy-to-use screening checklists, patient leaflets, or training presentations for Neftaly!

Comments

Leave a Reply